CPhI India Conference Series 2010
1-3 December 2010, The Westin Mumbai Garden City, Mumbai, India
Aug 21, 2010
By ,
Tag:
The CPhI India Conference Series 2010 has been developed to provide you with highly focused content and information covering the most critical issues in the Indian pharma industry.

CPhI India Conference Series 2010
1-3 December 2010
The Westin Mumbai Garden City
Mumbai, India
The CPhI India Conference Series 2010 has been developed to provide you with highly focused content and information covering the most critical issues in the Indian pharma industry.
Taking place alongside the CPhI India exhibition from 1-3 December at the nearby Westin Mumbai Garden City, the CPhI India Conference Series is designed to complement your visit to CPhI India. Each of our 12 conference modules will consist of three 30-minute presentations followed by a 30-minute interactive panel debate to provide you with the opportunity to have your questions answered.
Each module features in-depth analysis and case studies led by a line-up of carefully selected speakers from the leading pharmaceutical manufacturers and allied industries.
Choose from 12 modules across 3 intensive days:
Wednesday 1 December
1. Advanced API Strategies
2. Super Generics Trends & Opportunities
3. Exporting Hot-Spots & Strategies
4. Drug Discovery India
Thursday 2 December
5. Commercialising Biosimilars
6. Vaccine Product Opportunities
7. Nanotechnology Applications
8. Commercialising Stem Cells
Friday 3 December
9. Oncology Pipeline Trends
10. NDDS Platform Developments
11. Gearing up CRAM Infrastructure
12. Cost-Effective High-Yield Machinery
With our modular pricing structure, the more modules you book, the more money you save!
Plus, book your modules before 22 October 2010 to take advantage of our early bird discounts!
For more information, visit www.cphi-india.com or contact:
Pallavi Mhapankar
Customer Services Executive
Tel: +91 22 4046 1466
Fax: +91 22 4046 1477
Email:
conferences@ubmindia.com
If you believe an article violates your rights or the rights of others, please contact us.